NCT00150124View on ClinicalTrials.gov

Block-replacement Therapy During Radioiodine Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

December 31, 2008

Study Completion Date

March 31, 2009

Conditions
Toxic Nodular GoitreGraves' Disease
Interventions
DRUG

MTZ+LT4

DRUG

Methimazole

Trial Locations (1)

5000

Department of Endocrinology, Odense University Hospital, Odense

All Listed Sponsors
lead

Steen Bonnema

OTHER

NCT00150124 - Block-replacement Therapy During Radioiodine Therapy | Biotech Hunter | Biotech Hunter